Skip to content

Effectiveness of Passive Mobilization in Patients With Subacromial Syndrome

Effectiveness of Passive Mobilization of Glenohumeral Joint in Patients With Subacromial Syndrome: a Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03568006
Enrollment
22
Registered
2018-06-26
Start date
2018-07-01
Completion date
2018-09-17
Last updated
2018-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Subacromial Impingement

Keywords

subacromial impingement, pain, shoulder, passive mobilization

Brief summary

From a biomechanical point of view, subacromial syndrome causes an increment in the anterior and superior translation of the humeral head, which increases compression in the adjacent tissues of the subacromial space, aggravating the symptoms of the patients. Conservative treatments are the first option for subacromial syndrome management, despite the fact that there is limited evidence about its effectiveness, due to the lack of experimental studies. The aim of this study is to evaluate the effectiveness of a passive joint mobilization (caudal and dorsal gliding) grade II in the glenohumeral joint, within a multimodal approach to reduce pain and improve the range of motion in patients with subacromial syndrome.

Detailed description

Subacromial syndrome, also known as subacromial impingement, is the most frequent disorder in the shoulder joint. It has a multifactorial origin and represents a wide spectrum of pathologies. Its main consequences are pain and loss of function in the glenohumeral joint. From a biomechanical point of view, subacromial syndrome causes an increment in the anterior and superior translation of the humeral head, which increases compression in the adjacent tissues of the subacromial space, aggravating the symptoms of the patients. Conservative treatments are the first option for subacromial syndrome management, despite the fact that there is limited evidence about its effectiveness, due to the lack of experimental studies. The aim of this study is to evaluate the effectiveness of a passive joint mobilization (caudal and dorsal gliding) grade II in the glenohumeral joint, within a multimodal approach to reduce pain and improve the range of motion in patients with subacromial syndrome. To this end, a randomized clinical trial will be carried out in the Montpellier Clinic in Zaragoza. Twenty-two patients will be recruited and randomly assigned to one of the two groups (intervention and control). Both groups will receive a standardized treatment consisting of: 10 sessions of infrared rays, and a program of therapeutic exercises and indications to improve their postural hygiene. In addition, the intervention group will receive a passive joint mobilization in the glenohumeral joint of 5 minutes. Pain intensity, range of motion and functionality of the glenohumeral joint will be measured in the first session before any treatment and in the tenth session after the treatment.

Interventions

OTHERSpecific passive mobilization

Specific passive mobilizations for the shoulder

OTHERStandardized treatment (standard protocol)

Infrared rays, a program of therapeutic exercises and indications to improve their postural hygiene

Sponsors

Montpellier Clinic
CollaboratorUNKNOWN
Universidad San Jorge
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Masking description

It is not possible to mask physiotherapists and patients, so the only masking will be for researchers and evaluators

Eligibility

Sex/Gender
ALL
Age
30 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosis of subacromial syndrome * Pain at rest, which increases when doing active movements * Neer´s impingement test positive * Hawkins Kennedy test positive * Pain lasting more than one month * Anteriorization of humeral head * Full capacity (physical and cognitive) to participate in the study and give consent.

Exclusion criteria

* Infiltrations during the previous six months * Traumatic origin of pain * Complete tear of any rotator cuff tendon * Bilateral pain * Previous surgical intervention in the affected shoulder * Patients planning to start with other treatments during the clinical trial.

Design outcomes

Primary

MeasureTime frameDescription
Visual Analogue Scale (VAS)Change between baseline (immediately before intervention) and post intervention (2 weeks).10 centimetres Visual Analogue Scale. 0 is no pain, whilst 10 is maximum intolerable pain

Secondary

MeasureTime frameDescription
Active range of motionChange between baseline (immediately before intervention) and post intervention (2 weeks).Measurement of active range of motion for the different shoulder movements (abduction from 0 to 150º, flexion from 0 to 180º, extension from 0 to 60º, lateral rotation from 0 to 90º, internal rotation from o to 70º)
Constant ScoreChange between baseline (immediately before intervention) and post intervention (2 weeks).Scale to measure shoulder function, ranging from 0 to 100. These parameters define the level of pain and the ability to carry out the normal daily activities of the patient.\[1\] The Constant score was introduced to determine the functionality after the treatment of a shoulder injury. The test is divided into four subscales: pain (15 points), activities of daily living (20 points), strength (25 points) and range of motion: forward elevation, external rotation, abduction and internal rotation of the shoulder (40 points). The higher the score, the higher the quality of the function.

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026